Treeway BV:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Treeway BV - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10941
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Treeway BV (Treeway) is a biotechnology company that develops drugs for the treatment of amyotrophic lateral sclerosis (ALS). The company provides pipeline products such as TW001, an oral formulation of edaravone, which protects against neuronal apoptosis and oxidative stress. It offers products such as TW002, an AAV5-GDNF gene therapy that offers an innovative administration modality for clinical use. Treeway provides discovery research activities such as project minE, motor neuron signalling, the immune system, and others. The company collaborates with research and clinical institutes for performing clinical trials in ALS. Treeway is headquartered in Tilburg, the Netherlands.

Treeway BV – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Treeway BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Treeway BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Treeway BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Treeway BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Treeway BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Treeway BV, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Treeway Enters into Agreement with Cedars-Sinai Medical Center 10
Treeway Enters into Collaboration Agreement with LACDR 11
Treeway Enters into Collaboration Agreement with Amarna 12
Treeway Enters into Collaboration Agreement with myTomorrows 13
Licensing Agreements 14
Treeway Enters into Licensing Agreement with uniQure 14
Treeway BV – Key Competitors 15
Treeway BV – Key Employees 16
Treeway BV – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Treeway BV, Pharmaceuticals & Healthcare, Key Facts 2
Treeway BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Treeway BV, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Treeway BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Treeway BV, Deals By Therapy Area, 2012 to YTD 2018 8
Treeway BV, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Treeway Enters into Agreement with Cedars-Sinai Medical Center 10
Treeway Enters into Collaboration Agreement with LACDR 11
Treeway Enters into Collaboration Agreement with Amarna 12
Treeway Enters into Collaboration Agreement with myTomorrows 13
Treeway Enters into Licensing Agreement with uniQure 14
Treeway BV, Key Competitors 15
Treeway BV, Key Employees 16

List of Figures
Treeway BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Treeway BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Treeway BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Treeway BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Treeway BV, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Treeway BV, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Treeway BV, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Treeway BV, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Treeway BV:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PACO Integrated Energy, Inc. (formerly PACO Oil and Gas, Inc.):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' PACO Integrated Energy, Inc. (f …
  • Medical & Biological Laboratories Co., Ltd. (4557):企業の財務及び戦略的SWOT分析
    Summary Medical & Biological Laboratories Co., Ltd. (MBL) is a biotechnology company that develops and manufactures clinical diagnostics and basic laboratory diagnostics. The company’s products include research reagents, diagnostic reagents and companion diagnostics. It offers diagnostic reagents fo …
  • Alfa Laval AB (ALFA):企業の財務・戦略的SWOT分析
    Alfa Laval AB (ALFA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Kirovenergosbyt (KISB):企業概要、財務及び戦略的SWOT分析
    Summary JSC Kirovenergosbyt (Kirovenergosbyt) is a power generation company. The company purchases electricity from wholesale energy market and sells to retail consumers in Kirov oblast. It implements of electricity to consumers of the Kirov region. Kirovenergosbyt has nine interdistrict offices in …
  • SFC Co., Ltd. (112240):企業概要、財務及び戦略的SWOT分析
    Summary SFC Co., Ltd (SFC) is a photo voltaic back-sheet and inkjet media solution provider. The company offers its products through three categories including PV backsheet; inkjet media; and laminating and special films. Its photo voltaic backsheet products include PP 350, PP 350B, PP 350BW, SS320, …
  • Harbin Gloria Pharmaceuticals Co Ltd (002437):企業財務及び戦略的SWOT分析
    Summary Harbin Gloria Pharmaceuticals Co Ltd (Harbin Gloria) is a research and development company that produces and markets pharmaceutical drugs. The company’s product portfolio comprises pharmaceutical drugs for treating nutrition disorders, cardiovascular diseases, cancer and musculoskeletal diso …
  • Global Blood Therapeutics Inc (GBT):製薬・医療:M&Aディール及び事業提携情報
    Summary Global Blood Therapeutics Inc (GBT) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes novel oral medicines for the treatment of grievous blood-based disorders. The company's lead drug candidate GBT440 is an oral, small molecule drug for the treatment o …
  • Maersk Tankers AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Maersk Tankers AS (Maersk Tankers), a subsidiary of A.P. Moeller Holding AS is an oil and gas company that offers energy transportation services through oil tankers. The company provides services such as crude oil and refined oil transportation, warehousing and distribution, supply chain man …
  • Nichi-Iko Pharmaceutical Co., Ltd. (4541):企業の財務及び戦略的SWOT分析
    Summary Nichi-Iko Pharmaceutical Co., Ltd. (Nichi-Iko) is a pharmaceutical company that develops, produces, exports and imports generic drugs. The company’s products include acarbose tablets, alacepril tablets, aluminum hydroxide gel, aranidipine capsules, bacampicillin hydrochloride tablets, barium …
  • Regen BioPharma Inc (RGBP):製薬・医療:M&Aディール及び事業提携情報
    Summary Regen BioPharma Inc (Regen BioPharma), a subsidiary of Bio-Matrix Scientific Group Inc, is an immunology and immunotherapy space provider. The company concentrates on the development of immunotherapies and cancer stem cell therapies. Its product pipeline includes HemaXellerate, dCellVax, Dif …
  • Fichtner GmbH & Co KG:企業の戦略的SWOT分析
    Fichtner GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Monitise plcの企業概要及び財務/SWOT分析
    Monitise plc Fundamental Company Report provides a complete overview of the company’s affairs. All available data is presented in a comprehensive and easily accessed format. The report includes financial and SWOT information, industry analysis, opinions, estimates, plus annual and quarterly forecast …
  • Punjab National Bank:企業概要およびSWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Punjab National Bank" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strictly foll …
  • Tocris Bioscience:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Tocris Bioscience Mergers and A …
  • Sumitomo Forestry Co., Ltd. (1911):企業概要・SWOT分析
    This report is a crucial resource for industry executives and anyone looking to access key information about "Sumitomo Forestry Co., Ltd." The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Timetric strict …
  • Analytik Jena AG:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Analytik Jena AG Mergers and Ac …
  • Cisco Systems, Inc. (CSCO):企業のM&A・提携動向(エネルギー分野)
    Summary Cisco Systems, Inc. (Cisco) is a technology services provider, which designs, manufactures and sells Internet protocol (IP)-based networking systems and other products. Its product portfolio includes switches, routers, network access, IP telephony, optical networking, security, storage area …
  • Nissan Chemical Corp (4021):企業の財務・戦略的SWOT分析
    Nissan Chemical Corp (4021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Wal-Mart de Mexico, S.A.B. de C.V.:企業の戦略・SWOT・財務分析
    SummaryWal-Mart de Mexico, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the c …
  • Indiabulls Real Estate Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Indiabulls Real Estate Limited …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆